Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine and Neurofeedback for Cocaine Use Disorder
NCT06125054Phase 2Recruiting
- Start
- Feb 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketamine in cocaine use disorder (CUD). Started Feb 2024; status: recruiting.
02
Drugs
ketamine
03
Conditions
cocaine use disorder (CUD)
Beyond the preview
Go deeper on NCT06125054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06125054.